Active constituents: There are three major active constituents
in bladderwrack: iodine, alginic acid, and fucoidan.
The amount of iodine in bladderwrack is highly variable,4 probably as a result
of different amounts of iodine in the water where it grows. A reasonable portion of
bladderwrack may contain the U.S. adult recommended dietary allowance (RDA) of iodine (150
mcg). The RDA amount of iodine is believed to be necessary for maintenance of normal thyroid
function in adults (infants and children need proportionally less). Thus, in people with
insufficient iodine in their diet, bladderwrack may serve as a supplemental source of iodine.
Either hypothyroidism or goiter due to insufficient intake of iodine may possibly improve
with bladderwrack supplementation, though human studies have not confirmed this.
Alginic acid is a type of dietary fiber that can be used to
help relieve constipation and diarrhea. However, human studies have not been done on how
effective bladderwrack is for either of these conditions. An over-the-counter antacid,
Gaviscon®, containing magnesium carbonate and sodium alginate (the sodium salt of alginic
acid), has been shown to effectively relieve the symptoms of heartburn compared to other antacids in a double-blind
study.5 However, bladderwrack has not been studied for use in people with
heartburn. Bladderwrack might also help indigestion, though again clinical trials have not
been conducted. Calcium alginate (the calcium salt of alginic acid) has shown promise as an
agent to speed wound healing in animal
studies6 but has not been demonstrated to be effective in humans.
Alginic acid has also been shown to inhibit HIV in
the test tube.7 However, this effect has not been studied in humans. Alginic acid
may help lower LDL (“bad”)
cholesterol levels, according to animal studies.8 No human trials have studied
this effect of bladderwrack. It is widely used in food and pharmaceuticals as a thickener and
gelling agent.9
Fucoidan is another type of dietary fiber in bladderwrack that contains numerous sulfur
groups. According to test tube and animal studies, this appears to give fucoidan several
properties, such as lowering LDL cholesterol levels,10 lowering blood glucose
levels,11 anti-inflammatory activity,12 possible anticoagulant
effects,13 and antibacterial14 and anti-HIV activity.15
Though it has not been definitively proven, fucoidan is thought to prevent bacteria and
viruses from binding to human cells, a necessary step in starting an infection, as opposed to killing the microbes
directly.16 17 To date, no human clinical trials have been done with
fucoidan or bladderwrack to support their use for any of these conditions.
References:
1. Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide
for Health-Care Professionals. London: Pharmaceutical Press, 1996:124–6.
2. Mills SY. Out of the Earth: The Essential Book of Herbal
Medicine. Middlesex, UK: Viking Arkana, 1991:514–6.
3. Björvell H, Rössner S. Long-term effects of commonly
available weight reducing programmes in Sweden. Int J Obes 1986;11:67–71.
4. Norman JA, Pickford CJ, Sanders TW, et al. Human intake of arsenic and
iodine from seaweed based food supplements and health foods available in the UK. Food
Addit Contam 1987;5:103–9.
5. Chevrel B. A comparative crossover study on the treatment of heartburn
and epigastric pain: Liquid Gaviscon and a magnesium-aluminum antacid gel. J Int Med
Res 1980;8:300–3.
6. Barnett SA, Varley SJ. The effects of calcium alginate on wound
healing. Ann R Coll Surgeons Engl 1987;69:153–5.
7. Béress A, Wassermann O, Bruhn T, et al. A new procedure for the
isolation of anti-HIV compounds (polysaccharides and polyphenols) from the marine alga
Fucus vesiculosus. J Nat Prod 1993;56:478–88.
8. Vázquez-Freire MJ, Lamela M, Calleja JM. Hypolipidaemic activity
of a polysaccharide extract from Fucus vesiculosus L. Phytother Res
1996;10:647–50.
9. Lahaye M, Kaeffer B. Seaweed dietary fibres: Structure,
physico-chemical and biological properties relevant to intestinal physiology. Sci
Aliments 1997;17:564–84 [review].
10. Vázquez-Freire MJ, Lamela M, Calleja JM. Hypolipidaemic activity
of a polysaccharide extract from Fucus vesiculosus L. Phytother Res
1996;10:647–50.
11. Vázquez-Freire MJ, Lamela M, Calleja JM. A preliminary study of
hypoglycaemic activity of several polysaccharide extracts from brown algae: Fucus
vesiculosus, Saccorhiza polyschides and Laminaria ochroleuca.
Phytother Res 1996;10(suppl):S184–5.
12. Bartlett MR, Warren HS, Cowden WB, Parish DR. Effects of the
anti-inflammatory compounds castanospermine, mannose-6-phosphate and fucoidan on allograft
rejection and elicited peritoneal exudates. Immunol Cell Biol
1994;72:367–74.
13. Church FC, Mead JB, Treanor RE, Whinna HC. Antithrombin activity of
fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III and thrombin.
J Biol Chem 1989;264:3618–23.
14. Criado MT, Ferreirós CM. Toxicity of an algal mucopolysaacharide
for Escherichia coli and Neisseria meningitidis strains. Rev Esp
Fisiol 1984;40:227–30.
15. Moen LK, Clark GF. A novel reverse transcriptase inhibitor from
Fucus vesiculosus. Int Conf AIDS 1993;9(1):145, abstr. #PO-A03–0061.
16. Criado MT, Ferreirós CM. Toxicity of an algal mucopolysaacharide
for Escherichia coli and Neisseria meningitidis strains. Rev Esp
Fisiol 1984;40:227–30.
17. Lederman S, Gulick R, Chess L. Dextran sulfate and heparin interact
with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV. J Immunol
1989;143:1149–54.
18. Mills SY. Out of the Earth: The Essential Book of Herbal
Medicine. Middlesex, UK: Viking Arkana, 1991:514–6.
19. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete
German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American
Botanical Council and Boston: Integrative Medicine Communications, 1998:315.
20. Harrell BL, Rudolph AH. Kelp diet: A cause of acneiform eruption.
Arch Dermatol 1976;112:560 [letter].
21. Okamura K, Inoue K, Omae T. A case of Hashimoto’s thyroiditis
with thyroid immunological abnormality manifested after habitual ingestion of seaweed.
Acta Endocrinol 1978;88:703–12.
22. Kim JY, Kim KR. Dietary iodine intake and urinary iodine excretion in
patients with thyroid diseases. Yonsei Med J 41:22–8.
23. Walkiw O, Douglas DE. Health food supplements prepared from kelp--a
source of elevated urinary arsenic. Can Med Assoc J 1974;111:1301–2
[letter].
24. Conz PA, La Greca G, Benedetti P, et al. Fucus vesiculosus:
A nephrotoxic alga? Nephrol Dial Transplant 1998;13:526–7 [letter].